Life sciences news
-
Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure
Wednesday February 8th 2023
Read more
-
Annals of the Rheumatic Diseases publishes results from two bimekizumab Phase 3 studies in axial spondyloarthritis
Wednesday January 18th 2023
Read more
-
Oxurion announces the continuation of KALAHARI Phase 2, Part B Study in diabetic macular edema following interim analysis
Friday December 16th 2022
Read more
-
UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa
Friday December 9th 2022
Read more
-
Oxurion: Interim analysis for KALAHARI trial planned by year-end 2022 with full top-line data expected in second half of 2023
Monday November 21st 2022
Read more
-
Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia
Tuesday November 15th 2022
Read more
-
Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON
Tuesday November 15th 2022
Read more
-
Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)
Tuesday October 25th 2022
Read more
-
Your news here?
-
Mithra announces positive preclinical data demonstrating Estetrol’s efficacy in wound healing
Wednesday October 12th 2022
Read more
-
Indigo Diabetes announces first participant enrolled in the SHINE clinical trial
Thursday September 29th 2022
Read more
-
reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration
Wednesday August 31st 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator